EBV Reactivation Longitudinal Cohort Study, 100 Adults, 18-29, Australia
Summary
NIH registered observational cohort study NCT07536048 on ClinicalTrials.gov tracking EBV reactivation in 100 EBV seropositive adults aged 18-29 years in Australia. The prospective longitudinal study will follow participants over 6-12 months with no study interventions. Participants will undergo immunological and clinical data collection at designated study centers.
What changed
NIH registered a new observational cohort study on ClinicalTrials.gov focused on Epstein-Barr Virus reactivation. The study will enroll approximately 100 EBV seropositive adults aged 18-29 years at multiple centers across Australia and follow participants for 6-12 months.
This is a registry entry for an observational study and does not impose compliance obligations. Researchers and clinical sites in Australia conducting infectious disease or immunological research may find this study relevant for understanding EBV reactivation patterns in young adults.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years
Observational NCT07536048 Kind: OBSERVATIONAL Apr 17, 2026
Abstract
This multi-center, prospective, longitudinal cohort study is designed to gather immunological and clinical data on EBV reactivation in EBV seropositive adults aged 18 to 29 years.
This study will follow a cohort of approximately 100 EBV seropositive adults 18 to 29 years of age in Australia over a 6 or 12-month period.
Participants will not receive any study intervention (eg, study treatments, vaccines).
Conditions: Epstein-Barr Virus (EBV), Healthy Volunteers
Interventions: Investigational Procedure
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.